Global MRI Contrast Agents Market Growth 2025-2031

Global MRI Contrast Agents Market Growth 2025-2031

The global MRI Contrast Agents market size is predicted to grow from US$ 1543 million in 2025 to US$ 2201 million in 2031; it is expected to grow at a CAGR of 6.1% from 2025 to 2031.

MRI contrast agents are contrast agents used to improve the visibility of internal body structures in magnetic resonance imaging (MRI). The most commonly used compounds for contrast enhancement are gadolinium-based. Such MRI contrast agents shorten the relaxation times of nuclei within body tissues following oral or intravenous administration.

Global key MRI contrast agents core players include Bayer, Guerbet Group and Bracco Imaging etc. The top 3 companies hold a share about 82%. Asia-Pacific is the largest market with a share about 35%, followed by North America and Europe.

In terms of product, gadoterate meglumine product is the largest segment with a share about 27%. And in terms of applications, the largest application is hospital with a share about 84%.

LP Information, Inc. (LPI) ' newest research report, the “MRI Contrast Agents Industry Forecast” looks at past sales and reviews total world MRI Contrast Agents sales in 2024, providing a comprehensive analysis by region and market sector of projected MRI Contrast Agents sales for 2025 through 2031. With MRI Contrast Agents sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world MRI Contrast Agents industry.

This Insight Report provides a comprehensive analysis of the global MRI Contrast Agents landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on MRI Contrast Agents portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global MRI Contrast Agents market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for MRI Contrast Agents and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global MRI Contrast Agents.

This report presents a comprehensive overview, market shares, and growth opportunities of MRI Contrast Agents market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Gadobutrol
Gadoterate Meglumine
Gadobenate Dimeglumine
Gadopentetate Dimeglumine
Gadoteridol
Gadodiamine
Others

Segmentation by Application:
Hospitals
Clinics

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Bayer
Guerbet Group
Bracco Imaging
GE Healthcare
BeiLu Pharma
Hengrui Medicine

Key Questions Addressed in this Report

What is the 10-year outlook for the global MRI Contrast Agents market?

What factors are driving MRI Contrast Agents market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do MRI Contrast Agents market opportunities vary by end market size?

How does MRI Contrast Agents break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.